Detailansicht

Wissensnetz

Person

Ana Valeria Meléndez Mayorga

Biologin

Name	Ana Valeria Meléndez Mayorga
Ort	Deutschland Mexiko
Beruf	Biologin (charakteristischer Beruf)
Variante	Ana Valeria Meléndez Mayorga Ana Valeria Meléndez
Weitere Angaben	Dissertation 2022, Albert-Ludwigs-Universität Freiburg, Fakultät für Biologie
Datensatztyp	Person
GND-Nummer	1228324980
Datensatz-ID	1228324980
Beteiligt an alle anzeigen Harnessing CD3 diversity to optimize CAR T cells A Shiga toxin B-subunit-based lectibody boosts T cell cytotoxicity towards Gb3-positive cancer cells Dimeric lectin chimeras as novel candidates for gb3-mediated transcytotic drug delivery through cellular barriers Harnessing CD3 diversity to optimize CAR T cells A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death Lectin-based tools for cancer immunotherapy targeting the glycosphingolipid Gb3 Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells Bacterial lectin BambL acts as a B cell superantigen The Gb3-enriched CD59/flotillin plasma membrane domain regulates host cell invasion by Pseudomonas aeruginosa Bacterial lectin BambL acts as a B cell superantigen The Gb3-enriched CD59/flotillin plasma membrane domain regulates host cell invasion by Pseudomonas aeruginosa Septin remodeling is essential for the formation of cell membrane protrusions (microtentacles) in detached tumor cells

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Ana Valeria Meléndez Mayorga

Harnessing CD3 diversity to optimize CAR T cells

A Shiga toxin B-subunit-based lectibody boosts T cell cytotoxicity towards Gb3-positive cancer cells

Dimeric lectin chimeras as novel candidates for gb3-mediated transcytotic drug delivery through cellular barriers

Harnessing CD3 diversity to optimize CAR T cells

A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death

Lectin-based tools for cancer immunotherapy targeting the glycosphingolipid Gb3

Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells

Bacterial lectin BambL acts as a B cell superantigen

The Gb3-enriched CD59/flotillin plasma membrane domain regulates host cell invasion by Pseudomonas aeruginosa

Bacterial lectin BambL acts as a B cell superantigen

The Gb3-enriched CD59/flotillin plasma membrane domain regulates host cell invasion by Pseudomonas aeruginosa

Septin remodeling is essential for the formation of cell membrane protrusions (microtentacles) in detached tumor cells